Home > Drug Search >
  • company_query: Artielle ImmunoTherapeutics
  •   > 
Drug Filter
Category:
chemistry (9) biology (22)
Status:
Approved (3) BLA Filing (1) Phase Ⅲ (5) Phase Ⅱ (7) Phase Ⅰ (15)
Clinical Stage:
Pending (6) Active (18) Discontinued (4)
Bio-Type:
Gene therapy (2) Vaccine (12) Recombinant hormone/Synthetic peptide (1) Animal extract (1) Recombinant enzyme (1) Other recombinant protein (1) Whole antibody (2)
Indication:
Deep vein thrombosis (DVT) (1) Wet age-related macular degeneration (1) HCV infection (1) HIV infection (1) Rabies (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Prostate cancer (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (2) Varicella zoster virus infections (1) Solid tumours (3) Rotavirus infection (1) Type 2 diabetes (1) Streptococcal infection (1) Acute intermittent porphyria (1) Retinal dystrophies (1) Carotid stenosis (1) Head and neck cancer (1) Cervical intraepithelial neoplasia (1) Ankylosing Spondylitis (AS) (1) Unstable angina (1) Diagnostic agents (2) Hypertrophic cardiomyopathy (1) Cardiomyopathy (1) Glioma (1) Mesothelioma (1) Liver cancer (1) Human papillomavirus infections (HPV) (1) Spasticity (1) Scleroderma (1)
Country:
Aprv. Year:
1996 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top